COM:CYTOMX
CytomX Therapeutics
- Stock
Last Close
0.87
22/11 21:00
Market Cap
102.07M
Beta: -
Volume Today
1.23K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -15.14M - | -30.31M 100.16% | -35.37M 16.71% | -58.90M 66.51% | -43.10M 26.83% | -84.60M 96.30% | -102.24M 20.84% | -32.88M 67.83% | -83.61M 154.25% | -99.32M 18.79% | -569K 99.43% | |
depreciation and amortization | 655K - | 783K 19.54% | 1.21M 54.02% | 1.73M 43.70% | 1.65M 5.08% | 1.88M 14.53% | 2.60M 38.27% | 2.57M 1.23% | 2.71M 5.17% | 2.44M 9.72% | 2.17M 10.97% | |
deferred income tax | 10K - | 8K 20% | 8K 0% | 6K 25% | -513K 8,650% | -2.23M - | -236K 89.41% | 272K 215.25% | -31.13M - | |||
stock based compensation | 343K - | 553K 61.22% | 3.99M 620.80% | 10.10M 153.26% | 11.29M 11.81% | 16.88M 49.53% | 19.10M 13.17% | 14.79M 22.59% | 13.17M 10.95% | 13.13M 0.32% | 8.56M 34.80% | |
change in working capital | 5.96M - | 60.67M 918.35% | -248K 100.41% | 43.26M 17,543.55% | 189.97M 339.12% | -7.98M 104.20% | -59.32M 643.56% | 18.13M 130.57% | -54.70M 401.64% | -30.65M 43.96% | -62.51M 103.92% | |
accounts receivables | -237K - | -1.64M 591.14% | 1.13M 169.05% | -1.57M 238.73% | -7.83M 398.79% | 10.04M 228.32% | 84K 99.16% | -785K 1,034.52% | 8K 101.02% | -35.20M 440,050% | 32.55M 192.49% | |
inventory | 329K - | 188K 42.86% | 1.81M 861.17% | -253K 114.00% | 10.32M 4,178.66% | 19.91M 92.98% | -11.29M 156.69% | -11.12M 1.55% | 11.64M 204.72% | |||
accounts payables | 366K - | 660K 80.33% | 2.94M 346.06% | 1.76M 40.05% | -2.44M 238.30% | 261K 110.69% | -374K 243.30% | -857K 129.14% | -139K 83.78% | 68K 148.92% | -1.43M 2,197.06% | |
other working capital | 5.50M - | 61.46M 1,017.51% | -6.13M 109.97% | 43.32M 806.64% | 189.91M 338.43% | -38.20M 120.11% | -47.74M 24.99% | 30.89M 164.71% | -66.21M 314.33% | 4.47M 106.76% | -93.64M 2,192.91% | |
other non cash items | 169K - | 95K 43.79% | 3.01M 3,065.26% | 1.77M 41.00% | 11.09M 525.03% | -1.70M 115.34% | 1.60M 194.18% | 2.89M 80.21% | 3.13M 8.52% | 3.62M 15.38% | 27.44M 659.00% | |
net cash provided by operating activities | -8.01M - | 31.80M 497.13% | -27.41M 186.21% | -2.03M 92.59% | 170.37M 8,484.50% | -75.52M 144.33% | -140.48M 86.01% | 5.26M 103.74% | -119.03M 2,363.38% | -110.79M 6.93% | -56.03M 49.42% | |
investments in property plant and equipment | -732K - | -1.66M 127.19% | -1.59M 4.15% | -2.18M 36.51% | -1.56M 28.35% | -3.79M 142.98% | -3.50M 7.68% | -2.31M 33.97% | -1.61M 30.32% | -1.74M 8.14% | -840K 51.72% | |
acquisitions net | 121.27M - | -5.93M 104.89% | -83.20M 1,303.95% | 16.41M 119.72% | -24.10M 246.86% | |||||||
purchases of investments | -250.90M - | -121.52M 51.57% | -218.71M 79.98% | -204.60M 6.45% | -174.99M 14.47% | -199.11M 13.78% | -99.90M 49.83% | -424.83M - | ||||
sales maturities of investments | 122.75M - | 169.50M 38.09% | 99M 41.59% | 214.31M 116.48% | 258.19M 20.47% | 182.70M 29.24% | 124.00M 32.13% | 100M 19.35% | 275M 175% | |||
other investing activites | -817K - | 52K 106.36% | -121.27M 233,303.85% | 5.93M 104.89% | 83.20M 1,303.95% | -16.41M 119.72% | 24.10M 246.86% | |||||
net cash used for investing activites | -732K - | -1.66M 127.19% | -130.56M 7,750.99% | 45.86M 135.12% | -121.27M 364.43% | 5.93M 104.89% | 79.70M 1,244.94% | -18.72M 123.49% | 22.49M 220.15% | 98.26M 336.92% | -150.67M 253.34% | |
debt repayment | -724K - | -1.26M 73.48% | -3.07M 144.19% | -78K 97.46% | ||||||||
common stock issued | 81.78M - | 159K 99.81% | 19.96M 12,451.57% | 134.60M 574.43% | 1.60M 98.81% | 11.29M 604.62% | 107.71M 854.22% | 648K 99.40% | 30.23M 4,565.12% | |||
common stock repurchased | 6.71M - | |||||||||||
dividends paid | -6.71M - | |||||||||||
other financing activites | 3.42M - | 26.81M 683.69% | 74.69M 178.60% | 915K 98.77% | 3.84M 319.56% | 5.03M 30.97% | 25K 99.50% | 5.61M 22,320% | 2.50M 55.38% | |||
net cash used provided by financing activities | 2.70M - | 25.55M 847.50% | 153.40M 500.31% | 996K 99.35% | 23.80M 2,289.16% | 139.62M 486.75% | 1.63M 98.83% | 16.89M 938.29% | 110.21M 552.42% | 648K 99.41% | 30.23M 4,565.12% | |
effect of forex changes on cash | ||||||||||||
net change in cash | -6.04M - | 55.69M 1,021.61% | -4.57M 108.21% | 44.82M 1,079.95% | 72.90M 62.65% | 70.03M 3.94% | -59.15M 184.47% | 3.43M 105.81% | 13.67M 298.11% | -11.88M 186.90% | -176.48M 1,385.51% | |
cash at beginning of period | 14.75M - | 8.70M 40.98% | 64.40M 639.93% | 59.82M 7.10% | 104.64M 74.93% | 178.47M 70.54% | 248.49M 39.24% | 189.34M 23.80% | 192.78M 1.81% | 206.45M 7.09% | 193.65M 6.20% | |
cash at end of period | 8.70M - | 64.40M 639.93% | 59.82M 7.10% | 104.64M 74.93% | 177.55M 69.67% | 248.49M 39.96% | 189.34M 23.80% | 192.78M 1.81% | 206.45M 7.09% | 194.57M 5.75% | 17.17M 91.17% | |
operating cash flow | -8.01M - | 31.80M 497.13% | -27.41M 186.21% | -2.03M 92.59% | 170.37M 8,484.50% | -75.52M 144.33% | -140.48M 86.01% | 5.26M 103.74% | -119.03M 2,363.38% | -110.79M 6.93% | -56.03M 49.42% | |
capital expenditure | -732K - | -1.66M 127.19% | -1.59M 4.15% | -2.18M 36.51% | -1.56M 28.35% | -3.79M 142.98% | -3.50M 7.68% | -2.31M 33.97% | -1.61M 30.32% | -1.74M 8.14% | -840K 51.72% | |
free cash flow | -8.74M - | 30.14M 444.84% | -29.01M 196.25% | -4.21M 85.49% | 168.81M 4,111.74% | -79.31M 146.98% | -143.98M 81.54% | 2.95M 102.05% | -120.64M 4,189.49% | -112.53M 6.72% | -56.88M 49.46% |
All numbers in USD (except ratios and percentages)